Kymera Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. My name is (inaudible). I'm a member of the health care team at JPMorgan. And it's my pleasure today to introduce Nello Mainolfi, the founder, President and Chief Executive Officer of Kymera Therapeutics. As a quick reminder, if you'd like to ask a question, please do so using the Q&A tool at the bottom of your screens. And with that, I'll pass over to you, Nello.
Thanks, (inaudible). Thanks, everyone. Thanks for the opportunity to come here today virtually and present to you, tell you about Kymera. So I'd like to start with maybe Slide 3. And in the course of the presentation, we'll go through a couple of slides with questions. And those questions are questions that have defined the path at Kymera for the past 4, 4.5 years. So the first question around which we really founded the company in 2016 was, what if you could remove disease-causing protein with a small molecule-based technology? And what is, by doing so, you're able to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
